plerixafor has been researched along with Wounds and Injuries in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Deng, X; Han, X; Liu, H; Wang, N; Yan, W | 1 |
| Barbul, A; Busch, JI; Cervoni-Curet, FN; Kavalukas, SL; Niederhuber, JE; Stuelten, CH; Sutton, E; Wakefield, LM; Webster, JD | 1 |
| Allen, RJ; Haberman, ID; Lin, CD; Nguyen, PD; Saadeh, PB; Schachar, J; Soares, MA; Szpalski, C; Warren, SM | 1 |
| Chen, A; Cheng, P; Dong, Y; Guo, F; Huang, H; Liu, H; Qin, L; Xu, F; Yang, Q; Zhang, X | 1 |
| Allen, RJ; Carr, J; Chang, CC; Gupta, SM; Levine, JP; Lin, CD; Saadeh, PB; Tanaka, R; Tepper, OM; Warren, SM | 1 |
| Bach, HH; Baker, TA; Gamelli, RL; Majetschak, M; Saini, V; Tripathi, A | 1 |
6 other study(ies) available for plerixafor and Wounds and Injuries
| Article | Year |
|---|---|
CXCR4 antagonist delivery on decellularized skin scaffold facilitates impaired wound healing in diabetic mice by increasing expression of SDF-1 and enhancing migration of CXCR4-positive cells.
Topics: Acellular Dermis; Animals; Benzylamines; Cell Movement; Chemokine CXCL12; Cyclams; Diabetes Mellitus, Experimental; Granulation Tissue; Heterocyclic Compounds; Male; Mice; Receptors, CXCR4; Structure-Activity Relationship; Wound Healing; Wounds and Injuries | 2017 |
SDF-1α mediates wound-promoted tumor growth in a syngeneic orthotopic mouse model of breast cancer.
Topics: Analysis of Variance; Animals; Azo Compounds; Benzylamines; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Chemokine CXCL12; Collagen; Cyclams; Enzyme-Linked Immunosorbent Assay; Female; Heterocyclic Compounds; Immunohistochemistry; Mice; Mice, Inbred BALB C; Microarray Analysis; Signal Transduction; Statistics, Nonparametric; Wounds and Injuries | 2013 |
Combination therapy accelerates diabetic wound closure.
Topics: Animals; Becaplermin; Benzylamines; Cyclams; Diabetes Complications; Diabetes Mellitus, Experimental; Disease Models, Animal; Heterocyclic Compounds; Mice; Neovascularization, Physiologic; Proto-Oncogene Proteins c-sis; Skin Ulcer; Stem Cells; Wound Healing; Wounds and Injuries | 2014 |
Inhibition of SDF-1α/CXCR4 Signalling in Subchondral Bone Attenuates Post-Traumatic Osteoarthritis.
Topics: Animals; Benzylamines; Biomarkers; Bone and Bones; Bone Remodeling; Bone Resorption; Cartilage, Articular; Cell Differentiation; Chemokine CXCL12; Cyclams; Disease Models, Animal; Gene Expression; Heterocyclic Compounds; Male; Mice; Osteoarthritis; Osteoclasts; Receptors, CXCR4; Signal Transduction; Wounds and Injuries; X-Ray Microtomography | 2016 |
Decreased circulating progenitor cell number and failed mechanisms of stromal cell-derived factor-1alpha mediated bone marrow mobilization impair diabetic tissue repair.
Topics: Animals; Benzylamines; Bone Marrow Cells; Cell Count; Chemokine CXCL2; Chemotaxis; Cyclams; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Heterocyclic Compounds; Ischemia; Mice; Mice, Inbred C57BL; Skin; Stem Cells; Surgical Flaps; Wound Healing; Wounds and Injuries | 2010 |
Initial assessment of the role of CXC chemokine receptor 4 after polytrauma.
Topics: Animals; Benzylamines; Cyclams; Female; Heterocyclic Compounds; Interleukin-6; Leukocyte Count; Lipopolysaccharides; Male; Protein Binding; Receptors, Cell Surface; Receptors, CXCR4; Sus scrofa; Teichoic Acids; Tumor Necrosis Factor-alpha; Ubiquitin; Wounds and Injuries | 2012 |